Quantum Biopharma (QNTM) Income from Non-Controlling Interests (2023 - 2026)
Quantum Biopharma (QNTM) reported Income from Non-Controlling Interests of $160,031 for Q2 2026, compared with -$513,260 a year earlier.
Powered by 
Analysis
Quantum Biopharma (QNTM) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Quantum Biopharma's Income from Non-Controlling Interests came in at -$138,370; for FY2025, it was -$781,554.
- By year, Income from Non-Controlling Interests came in at -$712,805 in FY2024, -$328,409 in FY2023 and -$23.61 million in FY2022.
- Five-year quarterly Income from Non-Controlling Interests spans a low of -$5.49 million in Q2 2023 and a high of $571,429 in Q3 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$193,265 (Q1 2026), -$676,565 (Q4 2025) and $571,429 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Quantum Biopharma | 13.37 Mn | 1.18 Mn | - | 160,031.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160,031.00 |
| Mar 31, 2026 | -193,265.00 |
| Dec 31, 2025 | -676,565.00 |
| Sep 30, 2025 | 571,429.00 |
| Jun 30, 2025 | -513,260.00 |
| Mar 31, 2025 | -163,158.00 |
| Dec 31, 2024 | -96,015.00 |
| Sep 30, 2024 | -188,157.00 |
| Jun 30, 2024 | -240,583.00 |
| Mar 31, 2024 | -2.09 Mn |
| Dec 31, 2023 | -257,047.00 |
| Sep 30, 2023 | -71,362.00 |
| Jun 30, 2023 | -5.49 Mn |
API Access
Quantum Biopharma Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=QNTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "QNTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=QNTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();